Find relevant information on emerging treatments and feedback from actual patients.

Popular Treatments

• Hydroxyzine

  Brand Name: Atarax, Vistaril

  Drug Class: 1st generation antihistamine

  FDA Category: Prescription Medication

  3 Relevant Research Studies

  2 Ratings

  2 Comments

  640 Views

  Apr 16, 2024

• Melatonin

  Brand Name: NA

  Drug Class: Supplement

  FDA Category: supplement

  4 Relevant Research Studies

  1 Ratings

  1 Comments

  847 Views

  Apr 16, 2024

• Nattokinase

  Brand Name: NA

  Drug Class: Supplements

  FDA Category: supplement

  6 Relevant Research Studies

  Ratings

  0 Comments

  310 Views

  Apr 16, 2024

• Vitamin D

  Brand Name: NA

  Drug Class: Vitamin, Fat Soluble;...

  FDA Category: supplement

  7 Relevant Research Studies

  1 Ratings

  1 Comments

  513 Views

  Apr 16, 2024

• Oxaloacetate

  Brand Name: NA

  Drug Class: Supplement

  FDA Category: supplement

  7 Relevant Research Studies

  Ratings

  0 Comments

  280 Views

  Apr 16, 2024

• N-acetylcysteine

  Brand Name: Acetadote

  Drug Class: Antidote; Mucolytic Agent

  FDA Category: supplement

  13 Relevant Research Studies

  2 Ratings

  1 Comments

  454 Views

  Apr 16, 2024

• Metformin

  Brand Name: Fortamet, Glucophage, Glumetza,

  Drug Class: Anti-diabetic (biguanide)

  FDA Category: Prescription Medication

  2 Relevant Research Studies

  Ratings

  0 Comments

  225 Views

  Apr 16, 2024

• Neurofeedback (NFB)

  Brand Name: NA

  Drug Class: N/A

  FDA Category: other

  6 Relevant Research Studies

  Ratings

  0 Comments

  305 Views

  Apr 16, 2024

• Naltrexone

  Brand Name: Vivitrol, ReVia, Depade

  Drug Class: Opiate antagonist

  FDA Category: Prescription Medication

  6 Relevant Research Studies

  Ratings

  0 Comments

  322 Views

  Apr 16, 2024

• Propranolol

  Brand Name: Inderal, InnoPran, Hemangeol

  Drug Class: Beta blocker

  FDA Category: Prescription Medication

  2 Relevant Research Studies

  Ratings

  0 Comments

  260 Views

  Apr 16, 2024

View More...